Since 2014, specialising in Mergers & Acquisitions
DOWNLOAD PDF Introduction Although improvements in medical technology have accelerated at breakneck speed over the past decades, drug discovery has been seemingly inverting this trend. Since the 1950s, the chances of a drug successfully passing clinical trials and becoming a new molecular entity (NME) have been steadily declining. This was the observation that researchers at … Continue reading On Recursion–Exscientia and The Long Game of Reinventing Drug Discovery
“The Constitution imposes no obligation on the States ... to pay any of the medical expenses of indigents” US Supreme Court, 1977 The US is the only industrialized nation with selective healthcare coverage, meaning that basic healthcare services are not provided to everybody and paid for by the government (or government-managed entities), and this has … Continue reading American Beauty: The Healthcare Puzzle
A new Pharma Mega-Deal making Botox and Viagra join forces. On November 23, 2015, Pfizer announced its $160bn tie-up with Allergan to form the world’s biggest pharmaceutical company by sales. Industry Overview Even though recent M&A activity has started to slow down in the healthcare sector, the announced merger shows that the M&A frenzy is … Continue reading Pfizer – Allergan
Bocconi Students M&A Circle 
You must be logged in to post a comment.